Olmesartan is not associated with the risk of enteropathy: a Korean nationwide observational cohort study

Background/Aims Olmesartan, a widely used angiotensin II receptor blocker (ARB), has been linked to sprue-like enteropathy. No cases of olmesartan-associated enteropathy have been reported in Northeast Asia. We investigated the associations between olmesartan and other ARBs and the incidence of ente...

Full description

Bibliographic Details
Main Authors: Seng Chan You, Hojun Park, Dukyong Yoon, Sooyoung Park, Boyoung Joung, Rae Woong Park
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2019-01-01
Series:The Korean Journal of Internal Medicine
Subjects:
Online Access:http://www.kjim.org/upload/pdf/kjim-2017-002.pdf

Similar Items